John T Poirier

35PUBLICATIONS
174CO-AUTHORS
Molecular targetsMicro- and nanosystemsPredictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Dec 10, 2025
SLFN11 counteracts the RFWD3-PRIMPOL DNA damage tolerance axis to restrain gapped DNA synthesis in response to replication stress.

Kate E Coleman, Dong-Woo Shin, Liana Goehring

|Aug 16, 2024
An enhanced Eco1 retron editor enables precision genome engineering in human cells without double-strand breaks.

Matthew A Cattle, Lauren C Aguado, Samantha Sze

|Mar 27, 2024
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.

Ray Pillai, Sarah E LeBoeuf, Yuan Hao

|Nov 08, 2023
Inflammation in the tumor-adjacent lung as a predictor of clinical outcome in lung adenocarcinoma.

Igor Dolgalev, Hua Zhou, Nina Murrell

|Jul 10, 2023
Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer.

Ray Pillai, Sarah E LeBoeuf, Yuan Hao

|May 03, 2023
In vivo metabolomics identifies CD38 as an emergent vulnerability in LKB1 -mutant lung cancer.

Jiehui Deng, David H Peng, David Fenyo

Pageof 6

Frequent Collaborators

19 joint publications

Charles M Rudin

6 joint publications

Thales Papagiannakopoulos

5 joint publications

Charles M Rice

5 joint publications

Aristotelis Tsirigos